T1	Participants 49 93	patients with persistent atrial fibrillation
T2	Participants 156 197	AF patients with effective rhythm control
T3	Participants 203 237	patients treated with rate control
T4	Participants 270 332	266 AF patients randomized to rhythm control in the RACE study
T5	Participants 334 434	49 patients turned to long-term sinus rhythm and were continuously treated with oral anticoagulation
T6	Participants 548 640	256 rate-control patients of RACE who were in AF and using oral anticoagulation continuously
T7	Participants 1428 1460	AF under a rate-control strategy
T8	Participants 1238 1359	Among patients who remained on warfarin, those who mostly were maintained in sinus rhythm under a rhythm-control strategy
